Multicenter Results of Mitral Valve Surgery in Patients With Rheumatic Heart Disease

Beijing Anzhen Hospital1 site in 1 country4,000 target enrollmentJanuary 1, 2011

ConditionsOutcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease
Sponsor: Beijing Anzhen Hospital
Enrollment: 4000
Locations: 1
Primary Endpoint: all-cause mortality
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

rheumatic heart disease remains the majority valvular disease in low and middle income countries, which mostly affected mitral valve, surgical treatment is the most effective strategy to improve the outcomes of middle or late-stage RHD patient, however, whether mitral valve repair surgery is superior to replacement or other evolving interventional device remains controversial, this study aims to investigate the results of repair surgery compared with replacement or other treatment strategy from international multicenters.

Registry

clinicaltrials.gov

Start Date

January 1, 2011

End Date

April 1, 2024

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Beijing Anzhen Hospital

Responsible Party

Principal Investigator

Xu Meng

NO.9 department of Cardiac surgery center

Beijing Anzhen Hospital

Eligibility Criteria

Inclusion Criteria

•1、rheumatic heart disease 2、mitral valve disease 3、combined with other heart valve disease(aortic valve, tricuspid valve, pulmonary valve) 4、patients underwent initial mitral valve surgery or intervention

Exclusion Criteria

•1、congenital heart disease degenerative heart valve disease 2、isolated aortic valve or tricuspid valve, pulmonary valve disease( doesn't affect mitral valve ) 3、patients received more than 1 time mitral valve operation